Fitbit’s 3 new trackers want to destress you and eventually diagnose you
Fitbit has just launched three new fitness trackers: the Inspire 2, Versa 3, and the brand-new Fitbit Sense. While they focus on the requisite tracking metrics we’ve come to expect from Fitbit, the company is also hoping they’ll further impact users’ mindfulness of stress and, eventually, recognize warning signs for COVID-19, among other illnesses.
The Fitbit Sense retails for $330 and offers sensors for ECG (to be activated pending FDA clearance), skin temperature, and electrodermal activity (EDA) for quantifying stress levels. The Versa 3 comes in at $100 less for $230 and lacks those three sensors, while the Versa 2 still offers nearly the same features as its successor at a more amenable $180. Lastly, the Inspire 2—with its more simplistic, OLED touchscreen and better battery life—can be had for $100.
All three trackers come with complimentary memberships for new Fitbit Premium users, which lends insight into longer health trends and offers guided workouts and even one-on-one health coaching with tailored fitness regimens and consultations. The Sense and Versa 3 only get six free months, while Inspire 2 owners get even more bang for their buck with 12 months included. Fitbit users can also opt in to the company’s study, which tracks various biological metrics in an attempt to detect COVID-19 infection before the onset of more demonstrative symptoms.
Read 9 remaining paragraphs | Comments
from Tech – Ars Technica https://ift.tt/3jbypc1
Comments
Post a Comment